Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

The FDA approved Nuzolvence (zoliflodacin) for uncomplicated urogenital gonorrhea in patients aged 12 years and older weighing at least 35kg.

The phase 2 BESTOW trial evaluated the safety and efficacy of tegoprubart vs tacrolimus in the prevention of rejection in patients undergoing kidney transplantation.

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

Black box warning is the most serious from the U.S. Food and Drug Administration, and critics say there is no justification so far.

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Samuela ‘Ofanoa, Ph.D., from the University of Auckland in New Zealand, and colleagues examined what types of gout content are on TikTok and assessed their association with user engagement. The ...

A randomized controlled trial compared coronary artery plaque progression after androgen deprivation therapy using relugolix vs leuprolide in men with prostate cancer.